E-LIB Suche - Ergebnisse für: Shah, G.

1

DYNAMICS OF RADIOMIC FEATURES FOLLOWING BRIDGING THERAPY DE..:

Imber, B. S. ; Silverman, E. A. ; Leithner, D....
Hematological Oncology. 41 (2023) S2 - p. 93-94 , 2023

Link: https://doi.org/10.1002/..

2

RWD178 Real-World Treatment Patterns, Healthcare Resource U..:

Feng, C. ; Murphy, L. ; Engel-Nitz, N....
Value in Health. 26 (2023) 6 - p. S395 , 2023

Link: https://doi.org/10.1016/..

3

IMPACT OF RESPONSE TO SYSTEMIC BRIDGING THERAPY ON CLINICAL..:

Wills, B. ; Shouval, R. ; Flynn, J....
Hematological Oncology. 41 (2023) S2 - p. 199-201 , 2023

Link: https://doi.org/10.1002/..

4

1242 CO-MORBIDITY, FRAILTY AND EJECTION FRACTION IN OLDER H..:

Shah, G ; Nehikhare, I ; Obiechina, N...
Age and Ageing. 52 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

5

CNS radiotherapy as bridging prior to CAR T‐cell therapy fo..:

Cederquist, G. ; Hubbeling, H. ; Tringale, K....
Hematological Oncology. 41 (2023) S2 - p. 530-532 , 2023

Link: https://doi.org/10.1002/..

6

Multicenter experience with radiotherapy for relapse after ..:

Hubbeling, H. ; Figura, N. ; Ladbury, C....
Hematological Oncology. 41 (2023) S2 - p. 532-534 , 2023

Link: https://doi.org/10.1002/..

7

1251 FRAILTY PREVALENCE AND RISK OF SARCOPENIA IN OLDER HEA..:

Obiechina, N ; Michael, A ; Gill, A...
Age and Ageing. 52 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

8

Baseline perihaematomal oedema and CRP are not associated w..:

Hostettler, I.C. ; Sobowale, O.A. ; Wu, T.Y....
Brain and Spine. 2 (2022) - p. 101436 , 2022

Link: https://doi.org/10.1016/..

9

P886: AFRICAN AMERICAN PATIENTS WITH SMOLDERING MULTIPLE MY..:

Akhlaghi, T. ; Maclachlan, K. ; Korde, N....
HemaSphere. 6 (2022) - p. 778-779 , 2022

Link: https://doi.org/10.1097/..

10

Radiotherapy for Relapse after Chimeric Antigen Receptor T ..:

Hubbeling, H.G. ; Silverman, E.A. ; Tomas, A. Alarcon...
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. S56-S57 , 2022

Link: https://doi.org/10.1016/..

11

S177: EVALUATING SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKE..:

Akhlaghi, T. ; Maclachlan, K. ; Korde, N....
HemaSphere. 6 (2022) - p. 78-79 , 2022

Link: https://doi.org/10.1097/..

12

Patterns of Relapse and Risk Reduction Following Tumor Debu..:

Hubbeling, H.G. ; Silverman, E.A. ; Michaud, L....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. S135-S136 , 2022

Link: https://doi.org/10.1016/..

13

In situ process monitoring of nuclear waste glass melts usi..:

Sivaprakasam, Balamurugan T. ; Sugilal, G. ; Shah, J.G....
Measurement. 160 (2020) - p. 107793 , 2020

Link: https://doi.org/10.1016/..

14

TB/HIV coinfection and patient outcomes: Evidence from 241 ..:

Shah, G. ; Ewetola, R. ; Etheredge, G....
International Journal of Infectious Diseases. 101 (2020) - p. 293 , 2020

Link: https://doi.org/10.1016/..

15

Retention and predictors of attrition among children living..:

Traore-Toure, F. ; Etheredge, G. ; Shah, G..
International Journal of Infectious Diseases. 101 (2020) - p. 293 , 2020

Link: https://doi.org/10.1016/..